Coloplast A/S (CLPBF) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Instruments & Supplies Branche. Der Hauptsitz des Unternehmens ist in Humlebæk, Denmark. Der aktuelle CEO ist Lars Soren Rasmussen.
CLPBF hat IPO-Datum 2000-08-09, 16,741 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $13.54B.
Coloplast A/S is a Danish healthcare company founded in 1954 that develops and markets intimate healthcare products and services globally, with significant operations in North America and Europe. The company operates through four primary segments: Chronic Care, Interventional Urology, Voice and Respiratory Care, and Wound & Skin Care. Its product portfolio includes ostomy care solutions like SenSura and Brava brands, continence management products such as catheters and irrigation systems, wound and skin care dressings, and surgical devices for urological and gynecological conditions. The company also manufactures voice and respiratory care products for patients with neck and tracheal stomas under the Provox and TRACOE brands. Through its diversified product range and established market presence, Coloplast serves patients requiring specialized care for chronic conditions and post-surgical management.
